Figure 1

(A) Organization of full-length FUS and FUS165–422; (B) primary sequence of FUS165–422. The residues selected for replacement with cysteine and MTSL-labelling are marked with asterisk.

(A) Organization of full-length FUS and FUS165–422; (B) primary sequence of FUS165–422. The residues selected for replacement with cysteine and MTSL-labelling are marked with asterisk.